Wed, Aug 5, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Team member from absolute return Finaltis moves to systematic trend follower partner, KeyQuant

Thursday, November 01, 2012

Beverly Chandler, Opalesque London: Frans Harts is to join KeyQuant as Director of Sales & Marketing, reporting to the two KeyQuant co-founders, Robert Baguenault de Viéville and Raphaël Gelrubin from 1st November 2012.

Harts writes: "As many of you are aware, I have been working at Finaltis in Paris for the past 2 1/2 years. Finaltis was instrumental in helping KeyQuant get launched in December 2009, as well as seeding the Key Trends program with $6 million on January 8, 2010. I recently had a meeting with Denis Beaudoin (CEO, Finaltis) and Robert/Raphaël (KeyQuant PMs/Co-Founders), and based on the headway I have made marketing the Key Trends program, the four of us decided that the most logical next step for me was to join KeyQuant."

KeyQuant specializes in managing systematic trend following, focussing its research on obtaining high performance while maintaining a controlled risk and meeting its commitments. Finaltis is a financial management company specializing in managing absolute return directly and indirectly. It has been offering absolute return funds 2001, with a predilection for quantitative approaches.

The partnership between KeyQuant and Finaltis means that they have the serv......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

    Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

  4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

    Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

  5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

    Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,

 

banner